PT  - JOURNAL ARTICLE
AU  - Mills, Roger M.
AU  - Hobbs, Robert E.
TI  - How to use nesiritide in treating decompensated heart failure
DP  - 2002 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 252--256
VI  - 69
IP  - 3
4099  - http://www.ccjm.org/content/69/3/252.short
4100  - http://www.ccjm.org/content/69/3/252.full
SO  - Cleve Clin J Med2002 Mar 01; 69
AB  - Nesiritide (Natrecor), a synthetic formulation of B-type natriuretic peptide (BNP), is the first new parenteral agent to be approved for treating heart failure in more than a decade. In patients hospitalized with decompensated congestive heart failure, nesiritide promptly reduces pulmonary capillary wedge pressure, pulmonary arterial pressure, right atrial pressure, and systemic vascular resistance, resulting in clinical improvement.